The French Competition Authority has launched on 10 July 2013 a public Consultation entitled "How to revitalize competition in the distribution of medicines in cities?" ("Comment dynamiser la concurrence dans la distribution du médicament en ville?"). These are the preliminary conclusions reached by the Authority in the context of the sector inquiry into the pharmaceutical distribution sector launched in February 2013. The Authority identifies, in particular, the following competition concerns: (i) barriers to the development of generics, (ii) risks of collusion between pharmaceutical laboratories, (iii) tied sales and discrimination practices as regards over-the-counter drugs. Besides, the Authority calls for a strengthening of the role of the wholesalers and for a partial opening up to competition of the retail distribution of self-medication and “borderline products”. Interested third parties could submit their observations no later than 16 September 2013.